Long-Term Effects of Varying Alcohol Dosing in Percutaneous Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Randomized Study With a Follow-up up to 11 Years

Canadian Journal of Cardiology

Volumn 27, Issue 6, 2011, Pages 763-767

  Veselka, Josef ^a   Tomašov, Pavol ^a   Zemánek, David ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ABLATION THERAPY; ADULT; ALCOHOL SEPTAL ABLATION; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEATH; DRUG DOSE COMPARISON; DRUG MEGADOSE; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEMODYNAMICS; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESSURE GRADIENT; RANDOMIZED CONTROLLED TRIAL; REPEAT PROCEDURE;

ATRIAL SEPTUM; CARDIOMYOPATHY, HYPERTROPHIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; ETHANOL; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; INJECTIONS, INTRALESIONAL; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCLEROTHERAPY; SOLVENTS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR PRESSURE;

EID: 82155162442     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.09.001     Document Type: Article

References (18)

1. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2003, 24:1965-1991.
2. Sorajja P., Valeti U., Nishimura R.A., et al. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation 2008, 118:131-139.
3. Kimmelstiel C.D., Maron B.J. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 2004, 109:452-455.
4. Carrel T., Schmidli J. Septal myectomy for hypertrophic obstructive cardiomyopathy: coil, boil and the role of rescue surgery. Eur J Cardiothorac Surg 2009, 36:210-211.
5. Faber L., Seggewiss H., Welge D., et al. Echo-guided percutaneous septal ablation for symptomatic hypertrophic cardiomyopathy: 7 years of experience. Eur J Echocardiogr 2004, 5:347-355.
6. Kuhn H., Lawrenz T., Lieder F., et al. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10-year experience. Clin Res Cardiol 2008, 97:234-243.
7. Lawrenz T., Bochert B., Leuner C., et al. Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2011, 57:572-576.
8. Rigopoulos A.G., Seggewiss H. A decade of percutaneous septal ablation in hypertrophic cardiomyopathy. Circ J 2011, 75:28-37.
9. Veselka J., Zemánek D., Tomašov P., Duchoňová R., Linhartová K. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 mL) is still effective. Heart Vessels 2009, 24:27-31.
10. Veselka J., Duchoňová R., Procházková Š., et al. Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes. Am J Cardiol 2005, 95:675-678.
11. Veselka J., Procházková Š., Duchoňová R., et al. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome. Catheter Cardiovasc Interv 2004, 64:231-235.
12. Veselka J., Zemánek D., Fiedler J., Šváb P. Real-time myocardial contrast echocardiography for echo-guided alcohol septal ablation. Arch Med Sci 2009, 5:271-272.
13. Kimmelstiel C. Reducing arrhythmic complications following alcohol septal ablation-the utility of lower doses of ethanol. Catheter Cardiovasc Interv 2010, 75:551-552.
14. Lawrenz T., Leuner C., Schloesser M., et al. Influence of the dosage of ethanol on myocardial damage and LVOT obstruction after transcoronary ablation of septal hypertrophy in HOCM [abstract P3452]. Eur Heart J 2011, 32(suppl):589-590.
15. Sigwart U. Non-surgical myocardial reduction of hypertrophic obstructive cardiomyopathy. Lancet 1995, 346:211-214.
16. Kuhn H.J. The history of alcohol septal ablation. Cardiovasc Revasc Med 2010, 11:260-261.
17. Alam M., Dokainish H., Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. A systematic review of literature. J Intervent Cardiol 2006, 19:319-327.
18. Veselka J., Zemánek D., Tomašov P. Complications of low-dose echo-guided alcohol septal ablation. Catheter Cardiovasc Interv 2010, 75:546-550.